Bloodstream Infections (BSI) Completed Phase 3 Trials for Cefiderocol (DB14879)

Also known as: Blood Stream Infections / Bloodstream Infection (BSI) / Blood Stream Infection / Blood-stream Infections / Bloodstream Infections / Bloodstream Infection / Infection of bloodstream (disorder)

IndicationStatusPhase
DBCOND0079192 (Bloodstream Infections (BSI))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02714595Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative PathogensTreatment